Stem cell therapy has the potential to treat both Type 1 and Type 2 diabetes, but most research has focused on Type 1. This is because Type 1 diabetes is caused by a direct loss of insulin-producing cells, which can potentially be replaced by stem cell-derived cells. Type 2 diabetes, being a more complex metabolic disorder, may be more challenging to treat with this approach.